ID: ALA4450078

Max Phase: Preclinical

Molecular Formula: C25H33N5O4

Molecular Weight: 467.57

Molecule Type: Unknown

Representations

Canonical SMILES:  Nc1c(NC(=O)CC[C@H](Cc2ccccc2)NC(=O)[C@@H](N)C2CCCCC2)cncc1C(=O)O

Standard InChI:  InChI=1S/C25H33N5O4/c26-22(17-9-5-2-6-10-17)24(32)29-18(13-16-7-3-1-4-8-16)11-12-21(31)30-20-15-28-14-19(23(20)27)25(33)34/h1,3-4,7-8,14-15,17-18,22H,2,5-6,9-13,26H2,(H2,27,28)(H,29,32)(H,30,31)(H,33,34)/t18-,22+/m1/s1

Standard InChI Key:  WVVXZMSNRPPBDK-GCJKJVERSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 467.57

Molecular Weight (Monoisotopic): 467.2533

AlogP: 2.72

#Rotatable Bonds: 10

Polar Surface Area: 160.43

Molecular Species: ZWITTERION

HBA: 6

HBD: 5

#RO5 Violations: 0

HBA (Lipinski): 9

HBD (Lipinski): 7

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 3.66

CX Basic pKa: 9.33

CX LogP: 0.88

CX LogD: 0.07

Aromatic Rings: 2

Heavy Atoms: 34

QED Weighted: 0.36

Np Likeness Score: -0.20

References

1. Yamada K, Nakazawa M, Matsumoto K, Tagami U, Hirokawa T, Homma K, Mori S, Matsumoto R, Saikawa W, Kitajima S..  (2019)  Unnatural Tripeptides as Potent Positive Allosteric Modulators of T1R2/T1R3.,  10  (5): [PMID:31098002] [10.1021/acsmedchemlett.9b00051]

Source

Source(1):

• Scientific Literature